Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study

BACKGROUND: Dexamethasone intravitreal implant (DEX implant) is a biodegradable, sustained-release implant that releases dexamethasone for up to 6 months. We evaluated the efficacy and safety of DEX implant in the treatment of macular edema secondary to retinal vein occlusion (RVO) in treatment-naïv...

Full description

Saved in:
Bibliographic Details
Published in:BMC Ophthalmol
Main Authors: Dugel, Pravin U., Capone, Antonio, Singer, Michael A., Dreyer, Richard F., Dodwell, David G., Roth, Daniel B., Shi, Rui, Walt, John G., Scott, Lanita C., Hollander, David A.
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558971/
https://ncbi.nlm.nih.gov/pubmed/26337664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0106-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items